Lenalidomide-propargyl-C2-NH2 (hydrochloride), 25mg

2-(4-Chlorophenyl)-2-[4-(2-methylphenyl)piperazin-1-yl]acetic acid, 1g

Ethyl 7-chloro-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate, 97%, 250mg

2-Bromo-1-ethylpyridinium tetrafluoroborate, 98.0%, 1g

(S)-BENZYL 3-(HYDROXYMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 5g

Copper(II) nitrate trihydrate, min. 99.5%, pa, ACS, 10 g, glass packaging

1-Benzyl-1H-pyrazole-4-carbaldehyde, 95.0%, 5g

Diethyl (Ethoxymethyl)phosphonate>98.0%(GC)5g

1-Ethyl-5-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

4'-BROMOSPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE, 95.0%, 250mg

3-Amino-6-methylpyrazine-2-carboxylic acid, 1g

2-(1H-BENZO[D][1,2,3]TRIAZOL-1-YL)ETHANOL, 95.0%, 250mg

(S)-tert-Butyl 2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 95.0%, 250mg